Astrana Health/$ASTH
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Astrana Health
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
Ticker
$ASTH
Sector
Primary listing
Industry
Health Care Providers & Services
Headquarters
Employees
1,900
ISIN
US03763A2078
Website
Astrana Health Metrics
BasicAdvanced
$1.3B
35.08
$0.73
1.00
-
Price and volume
Market cap
$1.3B
Beta
1
52-week high
$61.38
52-week low
$23.12
Average daily volume
248K
Financial strength
Current ratio
1.698
Quick ratio
1.632
Long term debt to equity
83.715
Total debt to equity
87.187
Dividend payout ratio (TTM)
15.58%
Interest coverage (TTM)
2.43%
Profitability
EBITDA (TTM)
109.474
Gross margin (TTM)
11.94%
Net profit margin (TTM)
1.56%
Operating margin (TTM)
3.55%
Effective tax rate (TTM)
40.84%
Revenue per employee (TTM)
$1,180,000
Management effectiveness
Return on assets (TTM)
3.90%
Return on equity (TTM)
8.10%
Valuation
Price to earnings (TTM)
35.084
Price to revenue (TTM)
0.545
Price to book
1.68
Price to tangible book (TTM)
5.78
Price to free cash flow (TTM)
23.383
Free cash flow yield (TTM)
4.28%
Free cash flow per share (TTM)
109.53%
Growth
Revenue change (TTM)
54.81%
Earnings per share change (TTM)
-44.65%
3-year revenue growth (CAGR)
37.75%
3-year earnings per share growth (CAGR)
-21.60%
What the Analysts think about Astrana Health
Analyst ratings (Buy, Hold, Sell) for Astrana Health stock.
Bulls say / Bears say
Astrana Health reported a 40% year-over-year increase in total revenue to $486.3 million in Q2 2024, with net income rising 46% to $19.2 million, indicating strong financial performance. (stocktitan.net)
The company's strategic acquisition of Collaborative Health Systems expands its provider network across 17 states, serving over 129,000 beneficiaries, enhancing its value-based care capabilities. (stocktitan.net)
Analysts have shown confidence in Astrana Health, with Truist Securities upgrading the stock to a 'Buy' rating and setting a price target of $70.00, suggesting potential upside. (markets.businessinsider.com)
In Q4 2024, Astrana Health reported a net loss of $7.0 million, a decline from net income of $12.4 million in Q4 2023, raising concerns about profitability. (stocktitan.net)
The company's P/E ratio of 34.24 is higher than the market average of 25.21, indicating that the stock may be overvalued compared to peers. (marketbeat.com)
Astrana Health's stock price has experienced volatility, with a 52-week range between $23.12 and $63.20, which may concern risk-averse investors. (marketbeat.com)
Data summarised monthly by Lightyear AI. Last updated on 6 Jul 2025.
Astrana Health Financial Performance
Revenues and expenses
Astrana Health Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Astrana Health stock?
Astrana Health (ASTH) has a market cap of $1.3B as of July 11, 2025.
What is the P/E ratio for Astrana Health stock?
The price to earnings (P/E) ratio for Astrana Health (ASTH) stock is 35.08 as of July 11, 2025.
Does Astrana Health stock pay dividends?
No, Astrana Health (ASTH) stock does not pay dividends to its shareholders as of July 11, 2025.
When is the next Astrana Health dividend payment date?
Astrana Health (ASTH) stock does not pay dividends to its shareholders.
What is the beta indicator for Astrana Health?
Astrana Health (ASTH) has a beta rating of 1. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.